Kallyope is a biotechnology company. It integrates cutting-edge technologies in sequencing, bioinformatics, neural imaging, cellular and molecular biology. The company develops a platform that harnesses gut-brain axis.
|HQ||New York, NY, US||Map|
|Employees (est.) (Jan 2021)||62|
Kallyope total Funding
Kallyope latest funding size
Time since last funding
|10 months ago|
|Greenspring Associates, Polaris Partners, Lux Capital, Two Sigma Ventures, Illuminate Ventures, Illumina, The Column Group, Bill Gates, Casdin Capital, Alexandria Venture, Tony Evnin, Euclidean Capital, Alexandria Venture Investments, Illumina Ventures|
When was Kallyope founded?
Kallyope was founded in 2015.
Who are Kallyope key executives?
Kallyope's key executives are Nancy Thornberry, Ann Weber and Brett Lauring.
How many employees does Kallyope have?
Kallyope has 62 employees.
Who are Kallyope competitors?
Competitors of Kallyope include Second Genome, Cell Source and Capricor Therapeutics.
Where is Kallyope headquarters?
Kallyope headquarters is located at 430 E 29th St, New York.
Where are Kallyope offices?
Kallyope has an office in New York.
How many offices does Kallyope have?
Kallyope has 1 office.
Receive alerts for 300+ data fields across thousands of companies